Yingying Wang
wangyingying0822@126.com
English, Chinese, French
Chongqing
Chongqing Medical University
Basic Medical Sciences
  • 2002-2009 Bachelor and Master in Clinical Medicine: Wuhan University School of Medicine
  • 2010-2011 Master in Biomedical Engineering: University of Lorraine, France
  • 2011-2014 Doctorate in Life and Health Sciences: University of Lorraine, France
  • Led 1 national project and 1 university-level project, participated in 3 national projects
  • 2009-2010 - Wuhan University Zhongnan Hospital - Resident Physician
  • 2013-2014 - Mercy Hospital, University of Lorraine Regional Hospital - Resident Physician
  • 2015-2021.8 - Wuhan University Zhongnan Hospital - Attending Physician
  • 2021.10-present - Chongqing Medical University, School of Basic Medicine, Department of Immunology - Associate Professor
Mechanisms of chronic inflammation in bone marrow failure diseases
Impact of CMV and EBV infections on the immune system
Basic research and clinical application of virus-specific T cell therapy
  • Cytokines frequently implicated in myeloproliferative neoplasms, Wang Y, Zuo X, 2019
  • Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms, Wu S, Luo P, Yu Y, Xiong B, Wang Y, Zuo X, 2022
  • The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients, Wu S, Luo P, Rouzi T, Yu Y, Xiong B, Wang Y, Zuo X, 2023
  • Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection, Qian C, Wang YY, Cai H, Laroye C, De Carvalho Bittencourt M, Clement L, Stoltz JF, Decot V, Reppel L, Bensoussan D, 2016
  • Combination of Epstein-Barr virus nuclear antigen 1,3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy, Wang YY, Aissi-Rothe L, Virion JM, De Carvalho BM, Ulas N, Audonnet S, Salmon A, Laurence C, Venard V, Jeulin H, Bensoussan D, 2014
  • Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial, Qian, Chongsheng; Campidelli, Arnaud; Wang, Yingying; Cai, Huili; Venard, Veronique; Jeulin, Helene; Dalle, Jean Hugues; Pochon, Cecile; D'aveni, Maud; Bruno, Benedicte; Paillard, Catherine; Vigouroux, Stephane; Jubert, Charlotte; Ceballos, Patrice; Marie-Cardine, Aude; Galambrun, Claire; Cholle, Clement; Clerc Urmes, Isabelle; Petitpain, Nadine; De Carvalho Bittencourt, Marcelo; Decot, Veronique; Reppel, Loic; Salmon, Alexandra; Clement, Laurence; Bensoussan, Daniele, 2017
Chronic Inflammation Bone Marrow Failure Cmv Ebv Immune System T Cell Therapy Clinical Application Virus-Specific Mechanisms Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.